TD Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207M | Sell |
|
|||||
|
2025
Q1 | $236M | Buy |
|
|||||
|
2024
Q4 | $189M | Sell |
|
|||||
|
2024
Q3 | $242M | Buy |
|
|||||
|
2024
Q2 | $236M | Sell |
|
|||||
|
2024
Q1 | $215M | Sell |
|
|||||
|
2023
Q4 | $217M | Buy |
|
|||||
|
2023
Q3 | $167M | Buy |
|
|||||
|
2023
Q2 | $133M | Sell |
|
|||||
|
2023
Q1 | $122M | Buy |
|
|||||
|
2022
Q4 | $110M | Sell |
|
|||||
|
2022
Q3 | $129M | Sell |
|
|||||
|
2022
Q2 | $124M | Buy |
|
|||||
|
2022
Q1 | $114M | Buy |
|
|||||
|
2021
Q4 | $72.4M | Buy |
|
|||||
|
2021
Q3 | $58M | Sell |
|
|||||
|
2021
Q2 | $69.7M | Sell |
|
|||||
|
2021
Q1 | $103M | Sell |
|
|||||
|
2020
Q4 | $142M | Sell |
|
|||||
|
2020
Q3 | $169M | Buy |
|
|||||
|
2020
Q2 | $172M | Buy |
|
|||||
|
2020
Q1 | $138M | Buy |
|
|||||
|
2019
Q4 | $122M | Sell |
|
|||||
|
2019
Q3 | $96.4M | Buy |
|
|||||
|
2019
Q2 | $98.5M | Buy |
|
|||||
|
2019
Q1 | $95.5M | Buy |
|
|||||
|
2018
Q4 | $83.3M | Buy |
|
|||||
|
2018
Q3 | $94.9M | Buy |
|
|||||
|
2018
Q2 | $77.7M | Sell |
|
|||||
|
2018
Q1 | $81.7M | Buy |
|
|||||
|
2017
Q4 | $73.2M | Buy |
|
|||||
|
2017
Q3 | $68.8M | Buy |
|
|||||
|
2017
Q2 | $55.9M | Buy |
|
|||||
|
2017
Q1 | $45M | Buy |
|
|||||
|
2016
Q4 | $28.9M | Sell |
|
|||||
|
2016
Q3 | $38.8M | Sell |
|
|||||
|
2016
Q2 | $38.3M | Sell |
|
|||||
|
2016
Q1 | $37M | Buy |
|
|||||
|
2015
Q4 | $53.5M | Buy |
|
|||||
|
2015
Q3 | $39.3M | Buy |
|
|||||
|
2015
Q2 | $39.4M | Buy |
|
|||||
|
2015
Q1 | $37.6M | Buy |
|
|||||
|
2014
Q4 | $35.9M | Buy |
|
|||||
|
2014
Q3 | $33.1M | Buy |
|
|||||
|
2014
Q2 | $27.3M | Buy |
|
|||||
|
2014
Q1 | $18.2M | Buy |
|
|||||
|
2013
Q4 | $18.3M | Buy |
|
|||||
|
2013
Q3 | $15.9M | Buy |
|
|||||
|
2013
Q2 | $7.73M | Buy |
|